Strengthening Program for Pharmaceutical Startup Ecosystem [AMED Program]
AMED (Japan Agency for Medical Research and Development) is a Japanese government agency that plays a key role in promoting and subsiding medical research and development in Japan.
AMED’s Strengthening Program for Pharmaceutical Startup Ecosystem is specifically designed to address the challenges pharmaceutical startups face in securing substantial development funding, especially during critical stages such as non-clinical/pre-clinical studies, Phase I, Phase II, and exploratory clinical trials.
Download to learn more about the program!
